THREAD has announced a partnership with patient matching and enrollment platform Trialbee to streamline patient recruitment for sponsors and contract research organizations (CROs) on a global scale. The partnership combines THREAD’s DCT technology solution for remotely capturing data from trial participants with Trialbee’s platform for patient matching and enrollment in clinical trials, including those with rare conditions.
Participants are targeted for outreach based on a real-world, data-driven model. After completing the online prequalification process, participants receive virtual or phone-based nurse qualification interviews through a clinical call center before the information is sent to THREAD’s platform, where site staff make final assessments.
For more information, click here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.